You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The thoroughly revised, updated Fifth Edition of this classic is the m ost comprehensive, current, and authoritative reference on all anticon vulsants available today. This edition features detailed profiles of n ewer drugs--including levetiracetam, oxcarbazepine, tiagabine, topiram ate, and zonisamide--and new chapters on use of antiepileptic drugs in children and during pregnancy. Drugs are covered in alphabetical ord er and in an easy-to-follow format: mechanisms of action; chemistry, b iotransformation, and pharmacokinetics; interactions; clinical efficac y and use; and adverse effects. Coverage of clinical use includes none pileptic and psychiatric disorders where appropriate. This edition has been trimmed to manageable size by shortening chapters on older, less frequently used drugs.
A practical reference to the medical and surgicaltreatment of epilepsy The third edition of The Treatment of Epilepsy has beenthoroughly updated. It is a reference work, but has a strongpractical bias, and is designed to assist neurologists,neurosurgeons and other clinicians at all levels who are involvedin the treatment of patients with epilepsy. It is a definitivesource of clinical information to guide clinical practice andrational therapy. Written and edited by leading experts, many actively involvedwith the International League Against Epilepsy, this newedition: covers the recent advances in the principles and approaches toepilepsy therapy, the introduction of new drugs and the developmentof new surgical techniques contains 26 completely new chapters and 61 newcontributors includes pharmacological properties and prescribing informationfor all drugs used in the treatment of epilepsy features the important contribution of a new editor JeromeEngel Jr, Professor of Neurology at the University of CaliforniaSchool of Medicine in Los Angeles.
Epilepsy has a fascinating history. To the medical historian Oswei Temkin it was 'the paradigm of the suffering of both body and soul in disease'. It is justifiably considered a window on brain function. And yet its story is more than simply a medical narrative, but one influenced also by scientific, societal and personal themes. Written for a medical and non-medical readership, this book describes the major developments in epilepsy between 1860–2020, a turbulent era in which science dominated as an explanatory model, medical theories and practices steered an erratic course, and societal attitudes and approaches to epilepsy fluctuated dramatically. In the middle of this maelstrom was the person with epilepsy at the mercy of social attitudes and legislation, and at times harmed as well as helped by medicine and science. So entangled is the history that intriguingly, as an entity, epilepsy may now be thought not even to exist.
First multi-year cumulation covers six years: 1965-70.
First multi-year cumulation covers six years: 1965-70.
The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
Includes entries for maps and atlases.
The Wellcome Trust is a charitable institution supporting medical and allied research throughout the world. This History of the Trust marks the celebration of its fiftieth anniversary in 1986. Professor A. Rupert Hall, a prominent science historian, long associated with the Trust, and B. A. Bembridge, a retired Trust scientist, have written this lucid and well informed account which charts the development of the organisation from its inception in 1936 to the present day. Within this framework, there is an underlying discussion of the 'philosophy' of the financial endowment of science and medicine. The Wellcome Trust has had an enormous impact on medical research over the years. This volume provides a unique insight into the development of a leading scientific research body, and its relevance to similar institutions the world over.
Representing Epilepsy, the latest volume in Liverpool University Press’s acclaimed Representations series, is the first book that looks at the cultural and literary history of epilepsy, a condition that afflicts at least 50 million people worldwide. Jeannette Stirling argues that neurological discourse about epilepsy from the late nineteenth century through to the mid-twentieth century was forged as much by cultural conditions of the times as it is by the science of western medicine. Stirling also explores narratives of epilepsy in works as diverse as David Copperfield and The X Files, drawing out the many ideas of social disorder, tainted bloodlines, sexual deviance, spiritualism, and criminality they depict. This pathbreaking book will be required reading for cultural disability studies scholars and for anyone seeking a better understanding of this very common condition.
For twenty years this book, now in its 5th edition, has provided information on adverse drug interactions that is unrivalled in coverage and scholarship.Adverse drug reactions, many of them ascribable to interactions with other drugs or with chemical substances in food or the environment, are thought to cause or complicate one in twenty of hospital admissions.The book is conveniently divided into two parts: Part 1 comments on drug interactions and their mechanisms, on a pharmacokinetic and pharmacodynamic level, while Part 2 consists of drug interaction tables, divided and subdivided into categories of disorders, and the drugs used in the treatment of these disorders.If safety in drugs is to improve, education of prescribers is vitally important. This book, with its up-to-date and coordinated approach, serves that purpose well. The real threat, as the authors remind us, is the ignorance of practitioners, not the drug itself. The volume is therefore an essential addition to the shelves of those responsible for the prescription of drugs, in order to prevent a potential backlash when used in combination with other drugs or chemical substances.